Industry: Chemical & Material
Published Date: 2025-08-05
Pages: 153 Pages
Report ld: 4869393
Request Sample
Customized Report
Medical Polyacetal Resin Market Size(US$)

CAGR 2025-2031
6.8%
Market Size,2031
USD 209
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Medical Polyacetal Resin market is projected to grow from US$ 133 million in 2024 to US$ 209 million by 2031, at a CAGR of 6.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Polyacetal resin (Polyoxymethylene, abbreviated as POM) possesses properties ideal for medical device applications, including strength, rigidity, impact resistance, low wear, low friction, resilience, and creep resistance.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Medical Polyacetal Resin market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Medical Polyacetal Resin study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Medical Polyacetal Resin: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Medical Polyacetal Resin Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Homopolymer POM
1.2.3 Copolymer POM
1.3 Market Segmentation by Application
1.3.1 Global Medical Polyacetal Resin Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Dialysis Machine
1.3.3 Handles for Surgical Instruments
1.3.4 Inhalers
1.3.5 Insulin Pen
1.3.6 Medical Trays
1.3.7 Pharmaceutical Closures
1.3.8 Other Applications
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Medical Polyacetal Resin Revenue Estimates and Forecasts 2020-2031
2.2 Global Medical Polyacetal Resin Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Medical Polyacetal Resin Sales Estimates and Forecasts 2020-2031
2.4 Global Medical Polyacetal Resin Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Medical Polyacetal Resin Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
3.4.5 South Korea
4 Competition by Manufacturers
4.1 Global Medical Polyacetal Resin Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Medical Polyacetal Resin Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Homopolymer POM Market Size by Manufacturers
4.5.2 Copolymer POM Market Size by Manufacturers
4.6 Global Medical Polyacetal Resin Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Medical Polyacetal Resin Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Medical Polyacetal Resin Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Medical Polyacetal Resin Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Medical Polyacetal Resin Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Medical Polyacetal Resin Sales and Revenue by Type (2020-2031)
7.4 North America Medical Polyacetal Resin Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Medical Polyacetal Resin Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Medical Polyacetal Resin Sales and Revenue by Type (2020-2031)
8.4 Europe Medical Polyacetal Resin Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Medical Polyacetal Resin Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Medical Polyacetal Resin Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Medical Polyacetal Resin Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Medical Polyacetal Resin Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Medical Polyacetal Resin Sales and Revenue by Type (2020-2031)
10.4 Central and South America Medical Polyacetal Resin Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Medical Polyacetal Resin Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Medical Polyacetal Resin Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Medical Polyacetal Resin Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Medical Polyacetal Resin Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Kolon ENP
12.1.1 Kolon ENP Corporation Information
12.1.2 Kolon ENP Business Overview
12.1.3 Kolon ENP Medical Polyacetal Resin Product Models, Descriptions and Specifications
12.1.4 Kolon ENP Medical Polyacetal Resin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Kolon ENP Medical Polyacetal Resin Sales by Product in 2024
12.1.6 Kolon ENP Medical Polyacetal Resin Sales by Application in 2024
12.1.7 Kolon ENP Medical Polyacetal Resin Sales by Geographic Area in 2024
12.1.8 Kolon ENP Medical Polyacetal Resin SWOT Analysis
12.1.9 Kolon ENP Recent Developments
12.2 BASF SE
12.2.1 BASF SE Corporation Information
12.2.2 BASF SE Business Overview
12.2.3 BASF SE Medical Polyacetal Resin Product Models, Descriptions and Specifications
12.2.4 BASF SE Medical Polyacetal Resin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 BASF SE Medical Polyacetal Resin Sales by Product in 2024
12.2.6 BASF SE Medical Polyacetal Resin Sales by Application in 2024
12.2.7 BASF SE Medical Polyacetal Resin Sales by Geographic Area in 2024
12.2.8 BASF SE Medical Polyacetal Resin SWOT Analysis
12.2.9 BASF SE Recent Developments
12.3 Celanese Corporation
12.3.1 Celanese Corporation Corporation Information
12.3.2 Celanese Corporation Business Overview
12.3.3 Celanese Corporation Medical Polyacetal Resin Product Models, Descriptions and Specifications
12.3.4 Celanese Corporation Medical Polyacetal Resin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Celanese Corporation Medical Polyacetal Resin Sales by Product in 2024
12.3.6 Celanese Corporation Medical Polyacetal Resin Sales by Application in 2024
12.3.7 Celanese Corporation Medical Polyacetal Resin Sales by Geographic Area in 2024
12.3.8 Celanese Corporation Medical Polyacetal Resin SWOT Analysis
12.3.9 Celanese Corporation Recent Developments
12.4 Polyplastics Co., Ltd.
12.4.1 Polyplastics Co., Ltd. Corporation Information
12.4.2 Polyplastics Co., Ltd. Business Overview
12.4.3 Polyplastics Co., Ltd. Medical Polyacetal Resin Product Models, Descriptions and Specifications
12.4.4 Polyplastics Co., Ltd. Medical Polyacetal Resin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Polyplastics Co., Ltd. Medical Polyacetal Resin Sales by Product in 2024
12.4.6 Polyplastics Co., Ltd. Medical Polyacetal Resin Sales by Application in 2024
12.4.7 Polyplastics Co., Ltd. Medical Polyacetal Resin Sales by Geographic Area in 2024
12.4.8 Polyplastics Co., Ltd. Medical Polyacetal Resin SWOT Analysis
12.4.9 Polyplastics Co., Ltd. Recent Developments
12.5 Asahi Kasei Corporation
12.5.1 Asahi Kasei Corporation Corporation Information
12.5.2 Asahi Kasei Corporation Business Overview
12.5.3 Asahi Kasei Corporation Medical Polyacetal Resin Product Models, Descriptions and Specifications
12.5.4 Asahi Kasei Corporation Medical Polyacetal Resin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Asahi Kasei Corporation Medical Polyacetal Resin Sales by Product in 2024
12.5.6 Asahi Kasei Corporation Medical Polyacetal Resin Sales by Application in 2024
12.5.7 Asahi Kasei Corporation Medical Polyacetal Resin Sales by Geographic Area in 2024
12.5.8 Asahi Kasei Corporation Medical Polyacetal Resin SWOT Analysis
12.5.9 Asahi Kasei Corporation Recent Developments
12.6 SABIC
12.6.1 SABIC Corporation Information
12.6.2 SABIC Business Overview
12.6.3 SABIC Medical Polyacetal Resin Product Models, Descriptions and Specifications
12.6.4 SABIC Medical Polyacetal Resin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 SABIC Recent Developments
12.7 DuPont
12.7.1 DuPont Corporation Information
12.7.2 DuPont Business Overview
12.7.3 DuPont Medical Polyacetal Resin Product Models, Descriptions and Specifications
12.7.4 DuPont Medical Polyacetal Resin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 DuPont Recent Developments
12.8 Ensinger
12.8.1 Ensinger Corporation Information
12.8.2 Ensinger Business Overview
12.8.3 Ensinger Medical Polyacetal Resin Product Models, Descriptions and Specifications
12.8.4 Ensinger Medical Polyacetal Resin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Ensinger Recent Developments
12.9 Global Polyacetal
12.9.1 Global Polyacetal Corporation Information
12.9.2 Global Polyacetal Business Overview
12.9.3 Global Polyacetal Medical Polyacetal Resin Product Models, Descriptions and Specifications
12.9.4 Global Polyacetal Medical Polyacetal Resin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Global Polyacetal Recent Developments
12.10 Mitsubishi
12.10.1 Mitsubishi Corporation Information
12.10.2 Mitsubishi Business Overview
12.10.3 Mitsubishi Medical Polyacetal Resin Product Models, Descriptions and Specifications
12.10.4 Mitsubishi Medical Polyacetal Resin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Mitsubishi Recent Developments
12.11 Novameta
12.11.1 Novameta Corporation Information
12.11.2 Novameta Business Overview
12.11.3 Novameta Medical Polyacetal Resin Product Models, Descriptions and Specifications
12.11.4 Novameta Medical Polyacetal Resin Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 Novameta Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Medical Polyacetal Resin Industry Chain
13.2 Medical Polyacetal Resin Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Medical Polyacetal Resin Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Medical Polyacetal Resin Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Medical Polyacetal Resin Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Medical Polyacetal Resin Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Medical Polyacetal Resin market is projected to grow from US$ 110 million in 2025 to US$ 178 million by 2032, at a CAGR of 6.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-30
Pages: 129
USD 4900.00
(Single User License)
The global Medical Polyacetal Resin market size was US$ 110 million in 2025 and is forecast to reach a readjusted size of US$ 178 million by 2032 with a CAGR of 6.8% during the forecast period 2026-2032.
Published Date: 2026-07-30
Pages: 119
USD 4250.00
(Single User License)
The global market for Medical Polyacetal Resin was estimated to be worth US$ 110 million in 2025 and is projected to reach US$ 178 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-07-30
Pages: 116
USD 3950.00
(Single User License)
The global Medical Polyacetal Resin market was valued at US$ 110 million in 2025 and is anticipated to reach US$ 178 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published Date: 2026-07-30
Pages: 117
USD 2900.00
(Single User License)
The global market for Medical Polyacetal Resin was estimated to be worth US$ 133 million in 2024 and is forecast to a readjusted size of US$ 209 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published Date: 2025-09-13
Pages: 128
USD 3950.00
(Single User License)
The global Medical Polyacetal Resin market size was US$ 133 million in 2024 and is forecast to a readjusted size of US$ 209 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 95
USD 4250.00
(Single User License)
The global market for Medical Polyacetal Resin was valued at US$ 133 million in the year 2024 and is projected to reach a revised size of US$ 209 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published Date: 2025-03-10
Pages: 99
USD 2900.00
(Single User License)
Polyacetal resin (Polyoxymethylene, abbreviated as POM) possesses properties ideal for medical device applications, including strength, rigidity, impact resistance, low wear, low friction, resilience, and creep resistance.
Published Date: 2024-08-31
Pages: 104
USD 2900.00
(Single User License)
Polyacetal resin (Polyoxymethylene, abbreviated as POM) possesses properties ideal for medical device applications, including strength, rigidity, impact resistance, low wear, low friction, resilience, and creep resistance.
Published Date: 2024-08-31
Pages: 131
USD 4350.00
(Single User License)
Polyacetal resin (Polyoxymethylene, abbreviated as POM) possesses properties ideal for medical device applications, including strength, rigidity, impact resistance, low wear, low friction, resilience, and creep resistance.
Published Date: 2024-08-31
Pages: 161
USD 4900.00
(Single User License)
The global Medical Polyacetal Resin market is projected to grow from US$ 110 million in 2025 to US$ 178 million by 2032, at a CAGR of 6.8% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-30
Pages: 129
The global Medical Polyacetal Resin market size was US$ 110 million in 2025 and is forecast to reach a readjusted size of US$ 178 million by 2032 with a CAGR of 6.8% during the forecast period 2026-2032.
Published: 2026-07-30
Pages: 119
The global market for Medical Polyacetal Resin was estimated to be worth US$ 110 million in 2025 and is projected to reach US$ 178 million, growing at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-07-30
Pages: 116
The global Medical Polyacetal Resin market was valued at US$ 110 million in 2025 and is anticipated to reach US$ 178 million by 2032, at a CAGR of 6.8% from 2026 to 2032.
Published: 2026-07-30
Pages: 117
The global market for Medical Polyacetal Resin was estimated to be worth US$ 133 million in 2024 and is forecast to a readjusted size of US$ 209 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published: 2025-09-13
Pages: 128
The global Medical Polyacetal Resin market size was US$ 133 million in 2024 and is forecast to a readjusted size of US$ 209 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 95
The global market for Medical Polyacetal Resin was valued at US$ 133 million in the year 2024 and is projected to reach a revised size of US$ 209 million by 2031, growing at a CAGR of 6.8% during the forecast period.
Published: 2025-03-10
Pages: 99
Polyacetal resin (Polyoxymethylene, abbreviated as POM) possesses properties ideal for medical device applications, including strength, rigidity, impact resistance, low wear, low friction, resilience, and creep resistance.
Published: 2024-08-31
Pages: 104
Polyacetal resin (Polyoxymethylene, abbreviated as POM) possesses properties ideal for medical device applications, including strength, rigidity, impact resistance, low wear, low friction, resilience, and creep resistance.
Published: 2024-08-31
Pages: 131
Polyacetal resin (Polyoxymethylene, abbreviated as POM) possesses properties ideal for medical device applications, including strength, rigidity, impact resistance, low wear, low friction, resilience, and creep resistance.
Published: 2024-08-31
Pages: 161
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now